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n 
 
Drosophila
 
, myoblasts are subdivided into founders
and fusion-competent myoblasts (fcm) with myotubes
forming through fusion of one founder and several
fcm. Duf and rolling pebbles 7 (Rols7; also known as
antisocial) are expressed in founders, whereas sticks and
stones (SNS) is present in fcm. Duf attracts fcm toward
founders and also causes translocation of Rols7 from the
cytoplasm to the fusion site. We show that Duf is a type 1
transmembrane protein that induces Rols7 translocation
speciﬁcally when present intact and engaged in ho-
mophilic or Duf–SNS adhesion. Although its membrane-
I
 
anchored extracellular domain functions as an attractant
and is sufﬁcient for the initial round of fusion, subsequent
fusions require replenishment of Duf through cotransloca-
tion with Rols7 tetratricopeptide repeat/coiled-coil do-
main-containing vesicles to the founder/myotube surface,
causing both Duf and Rols7 to be at fusion sites between
founders/myotubes and fcm. This implicates the Duf–
Rols7 positive feedback loop to the occurrence of fusion
at speciﬁc sites along the membrane and provides a
mechanism by which the rate of fusion is controlled.
 
Introduction
 
Skeletal muscle fibers are syncytia that form from the fusion of
mono-nucleated myoblasts during embryogenesis (Hauschka,
1994). Growth and repair of the muscles in the adult also re-
quire myoblast fusion. In 
 
Drosophila,
 
 the somatic muscles
(analogous to the vertebrate skeletal muscles) comprise 
 
 
 
30
distinct muscles that are segmentally reiterated in a stereo-
typical pattern. Each of these muscles arises through fusion
between two types of myoblasts, the founders and fusion-com-
petent myoblasts (fcm), with the largest muscles containing
 
 
 
25 nuclei, whereas the smallest is made up of approximately
four (Baylies et al., 1998; Frasch and Leptin, 2000; Dworak
and Sink, 2002). Parallels at the cellular, subcellular, and mo-
lecular levels between the fusion process here and in verte-
brates, and the ability to genetically dissect the process render
the former an attractive model to study the cues that control
myotube formation and enlargement (Abmayr et al., 2003).
During embryogenesis in 
 
Drosophila
 
, mesodermal cells
expressing high levels of the transcription factor 
 
twist
 
 acquire a
myoblast cell fate, and from within this population, a subset of
 
lethal-of-scute
 
–expressing myoblasts is selected through Notch-
mediated lateral inhibition to become founders; the remaining
 
twist
 
-expressing cells differentiate into fcm. This partitioning
leads to the conferment of distinct properties upon each popula-
tion of myoblasts. Soon after birth, each founder initiates ex-
pression of a unique combination of transcription factors (e.g.,
Even-skipped [Eve]), collectively referred to as muscle identity
genes, which direct differentiation toward a particular muscle
fate. The fcm, in comparison, are relatively homogenous and do
not appear to be preassigned to any muscle fate. Second, founders
produce myoblast attractants, whereas fcm express ligands for
these. This results in movement of fcm toward founders and
eventually contact between several fcm with one founder, thus
establishing directionality to the fusion process. Upon fusion, the
newly incorporated nuclei within the syncytium are “entrained”
by the founder to express its identity genes, directing the entire
myotube toward a specific differentiation program. By being the
cellular entity at the center of the fusion process, founders seed
myotube formation. In addition, as bearers of identity cues, the
seeding event ensures that each founder develops into a muscle
with unique characteristics, which includes having a defined size.
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Although a large number of fcm cluster in the vicinity of
founders, adhesion usually occurs between a founder and just
one or two fcm. The fusing partners align against one another
and the closely apposed cell membranes breakdown to give
cytoplasmic continuity. Hence, fusion first yields a bi- or tri-
nucleated myotube called the syncytial precursor (Bate, 1990).
The precursor attracts and fuses with more fcm, enlarging in
size until it reaches its final size as defined by its founder spec-
ification program. Intriguingly, although the larger surface area
of a nascent myotube membrane could support multiple simul-
taneous fusions, this is not seen. Instead, the growth of the
myotube occurs in stages, each time through fusion with two or
three fcm at discrete regions along its surface. Analyses using
EM reveal an aggregate of electron dense vesicles lining the
membranes of founders/nascent myotubes and fcm at points of
contact (Doberstein et al., 1997). Subsequently, electron-dense
plaques form along these sites, possibly arising from the depo-
sition of the contents from the vesicles. The nature of the vesic-
ular content and its role in fusion are not known.
Genetic studies have now identified a number of mole-
cules that mediate myoblast fusion. 
 
dumbfounded
 
 (
 
duf
 
; also
known as kin-of-irre) is expressed specifically in founders just
before the onset of fusion and encodes a myoblast attractant
(Ruiz-Gomez et al., 2000; Strunkelnberg et al., 2001). Its tran-
script is thought to encode a transmembrane (TM) protein with
a single membrane-spanning region. This, together with its role
as a myoblast attractant, has led to two alternative proposals
concerning its mode of action. First, Duf may be cleaved to re-
lease its putative extracellular (EC) region. Fcm move toward
founders by “sensing” gradients of the secreted chemoattrac-
tant. On the other hand, the intact 
 
duf
 
 protein may anchor to the
cell surface where fcm detect its presence through random con-
tacts with founders. 
 
roughest
 
 (
 
rst
 
; also known as irregular chi-
asm-C) appears to have a similar function because embryos
lacking both 
 
duf
 
 and 
 
rst
 
 exhibit disrupted attraction, and conse-
quently fusion, whereas single mutants of either have a wild-
type (WT) musculature (Strunkelnberg et al., 2001). Consis-
tently, reintroduction of either of these proteins in double
mutants restores fusion. The distribution of the 
 
sticks and stones
 
(
 
sns
 
) and 
 
hibris
 
 (
 
hbs
 
) proteins at the fcm cell surface, and loss
of myoblast attraction in 
 
sns
 
 mutant embryos suggest that these
molecules actively participate in or modulate this process
(Bour et al., 2000; Artero et al., 2001; Dworak et al., 2001).
The scaffold-like 
 
rolling pebbles 7
 
 (
 
rols7
 
; also known as anti-
social) protein is another component of the fusion machinery
that shows a differential distribution pattern (Chen and Olson,
2001; Menon and Chia, 2001; Rau et al., 2001). Like 
 
duf/rst
 
,
Rols7 is expressed in founder myoblasts before fusion and is
seen to translocate from the cytosol to sites of fcm adhesion in
a Duf-dependent manner. In doing so, it recruits an element of
the cytoskeleton, D-Titin, to the fusion site. As Rols7 translo-
cation and D-Titin recruitment occur even in the absence of
 
sns
 
, where random contact between founders and fcm is rarely
seen, it has been postulated that these events might be constitu-
tive thereby implicating the presence of preformed sites spe-
cialized for fusion on the founder cell membrane (Menon and
Chia, 2001). Similarly, Duf causes translocation of the guanine
nucleotide exchange factor Loner, which then recruits and acti-
vates the ARF6 and D-Rac GTPases at the fusion site (Chen et
al., 2003). The involvement of both these small GTPases, 
 
kette
 
(and thus, actin; Schroter et al., 2004) and D-Titin in fusion
highlight the need for cytoskeletal reorganization during fusion.
It is conceivable that the role of Duf as a translocator of various
cytoplasmic fusion effectors could be mediated through the
intact protein or a part thereof, as suggested by coimmunopre-
cipitation with Rols7 (Chen and Olson, 2001).
In this paper, we show that Duf is a rate-limiting factor in
myoblast fusion. Its expression on the surface of founders and
actively fusing myotubes is tightly regulated. In addition,
Rols7 translocation is not constitutive but induced by founder/
myotube-fcm adhesion (or founder–founder adhesion in 
 
sns
 
and 
 
hbs;sns
 
 mutants) mediated through the intact Duf receptor.
With the translocation of Rols7-associated vesicles, the level of
Duf at the precursor surface is replenished and this promotes
myotube enlargement through more rounds of myoblast fusion.
 
Results
 
Duf encodes a type 1 TM protein 
that must remain intact for Rols7 
to translocate
 
The 
 
duf
 
-dependent translocation of Rols7 can be reproduced in
nonmesodermal tissues that do not normally express these pro-
teins. When Rols7 alone is expressed in the embryonic epider-
mal epithelium or salivary gland, it is seen throughout the cyto-
Figure 1. Rols7 translocates to adherence junctions in polarized non-
mesodermal tissues when Duf is present. Rols7 was expressed in epider-
mal (A and B) or salivary gland (C and D) epithelium using the gal4-UAS
system. Embryos were stained with antibodies against Rols7 (green) and
Crumbs, a marker for adherence junctions (red). Dashes outline epidermal
cell or salivary gland. 
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plasm in distinct puncta (Fig. 1, A and C, Rols7, green). In the
presence of Duf, the Rols7 puncta become enriched along the
apical membrane at adherence junctions identified by Crumbs
expression, suggesting conservation of the translocation mech-
anism seen in the mesoderm (Fig. 1, B and D, Crumbs, red).
To analyze domains of Duf necessary for the transloca-
tion event, we first verified the topology of this putative TM
protein. Cos cells were transfected with plasmids that express
an NH
 
2
 
- or COOH-terminal Flag epitope-tagged Duf and then
stained with anti-Flag antibodies. In permeabilized cells, the
staining pattern using either tagged construct is similar, and
Duf is seen along the cell surface (Fig. 2, A and C). In contrast
in cells that are not permeabilized and thus impenetrable
to antibodies, only NH
 
2
 
-terminal–tagged Duf (Flag-Duf) is
detectable at the cell periphery, whereas cells expressing
COOH-terminal–tagged Duf (Duf-Flag) show no staining at all
(Fig. 2, compare B with D). Together, these results show that
Duf is located at the cell surface as a type 1 TM protein, i.e.,
with an EC NH
 
2
 
-terminal region.
We created Flag-tagged truncations of Duf and examined
where these, in comparison to Flag-tagged full-length Duf, lo-
calize to in polarized cells. We also ascertained if the con-
structs retained the ability to recapitulate Rols7 translocation
(see Fig. 4 M for schematic structure of Duf constructs. All
constructs were sequenced in their entirety and express similar
levels of protein in whole extracts from embryos as detected by
Western blot; unpublished data). Full-length Duf tagged at its
COOH terminus is seen at the apical surface, including the
adherence junctions (Duf-Flag; Fig. 2 E, overlap between
Crumbs and Flag, yellow). A construct retaining the EC and
putative TM regions but with the intracellular (IC) region re-
placed by a Flag tag, NT(TM)-Flag, is also clearly seen at the
apical cell surface (Fig. 2 F). However, a deletion that extends
further from the COOH-terminal into the construct, thus re-
moving the putative TM sequence no longer anchors to the cell
membrane and NT-Flag is secreted into the lumen (Fig. 2 G).
Flag-Duf, where the tag is positioned at the NH
 
2
 
 terminus
of full-length Duf, is detected along the apical surface, particu-
larly the junctions, in all embryos examined using antibodies
raised against the Duf COOH-terminal region (Fig. 2 H). How-
ever, using anti-Flag antibodies, this construct is sometimes
seen in small patches along the apical membrane that alternate
rather than overlap with Crumbs, suggesting that it is present at
the apical surface other than the adherence junctions (Fig. 2 H,
inset). In most embryos, it cannot be detected using anti-Flag
antibodies. It is likely that this difference in detection arises
from masking of the Flag epitope (see Discussion). Flag-
(TM)CT, where most of the EC region is deleted and replaced
by an NH
 
2
 
-terminal Flag tag followed by the putative TM and
IC regions, is also detected in small patches along the apical
membrane that alternate rather than overlap with Crumbs using
anti-Flag antibodies (Fig. 2 I). Detection using antibodies
raised against the Duf IC region reveals a similar staining pat-
tern, suggesting that this construct is largely excluded from
adherence junctions (Fig. 2 I, inset). A deletion that extends
further from the NH
 
2
 
 terminus, thereby removing the putative
TM region, no longer anchors to the cell membrane and Flag-
CT appears throughout the cytoplasm (Fig. 2 J). Together,
these results show that the putative TM region of Duf indeed
functions as a membrane anchor. In addition, localization at
adherence junctions requires its EC region to be present.
When coexpressed with Rols7, only full-length Duf
causes Rols7 to translocate (Fig. 2 K). Notably, the mem-
brane-anchored Duf IC region does not bring about transloca-
tion, although it has been reported to interact with Rols7 in
Figure 2. The intact Duf type 1 TM protein induces Rols7 to translocate.
(A–D) Duf localization and topology. Full-length Duf Flag-tagged at its
NH2 (A and B) or COOH terminus (C and D) was expressed in Cos cells.
Cells were stained with anti-Flag antibodies (green), anti-tubulin antibod-
ies (red), and Hoechst (blue). (E–J) Full-length or truncated Duf was ex-
pressed in the salivary gland and detected using antibodies against Flag
(green, constructs shown schematically in Fig. 4 M). Crumbs marks adher-
ence junctions (red). (K–M) Coexpression of Flag-tagged Duf constructs
(red) and Rols7 (green) in the salivary gland. NT, NH2-terminal/EC; CT,
COOH-terminal/IC. Position of tag in construct indicated by where “Flag”
is placed in nomenclature. Dashes outline salivary gland. 
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immunoprecipitation assays when both Duf and Rols7 are co-
expressed in 
 
Drosophila
 
 S2 cells (Fig. 2 L; Chen and Olson,
2001). Concurrent expression of membrane-anchored EC and
IC regions of Duf from two separate plasmids also does not
induce Rols7 to translocate, suggesting that translocation re-
quires the Duf receptor to remain intact (Fig. 2 M).
 
Translocation occurs only where 
Duf is engaged in homophilic 
or Duf:SNS–directed adhesion
 
We next examined if cell type–specific differences might con-
tribute to the interaction between the Duf IC region and Rols7
reported in S2 cells. In these nonpolarized cells, full-length and
membrane-anchored truncations of Duf localize at the cell sur-
face (Fig. 3, A–C). Expression of full-length Duf or its mem-
brane-anchored EC region NT(TM)-Flag causes transfected
cells to cluster and these proteins are enriched at the adhesion
site (Fig. 3, A and B). This indicates that the EC region of Duf
is sufficient to bring about homophilic interaction in trans.
Rols7 when expressed alone, is seen in distinct cytoplasmic
puncta and the transfected cells do not cluster (Fig. 3 D).
The Rols7 puncta aggregate at the cell surface only in
the presence of full-length Duf (Fig. 3, E, F, H, and J). Impor-
tantly, translocation is restricted to sites where Duf engages
in cell–cell contact and not elsewhere along the periphery
where Duf is also present (Fig. 3 F, cell on the left shows Duf
all around the cell surface but Rols7 enrichment is exclu-
sively at site of adhesion). Translocation also occurs when
cells coexpressing full-length Duf and Rols7 adhere to SNS-
expressing cells, with the Rols7 puncta aggregating along ad-
hesion sites (unpublished data). Cells that express both Duf
and Rols7 but are isolated from other Duf/SNS-expressing
cells or in close proximity to cells that only express Rols7
also fail to show Rols7 translocation (Fig. 3 G). From this, it
appears that Rols7 translocation does not arise through Duf-
mediated targeting of preassembled Duf–Rols7 complex or
constitutive delivery of nascent Rols7 to sites where Duf is
surface localized. Rather, the engagement of the EC region of
Figure 3. Engagement of the Duf receptor through ho-
mophilic or Duf–SNS adhesion initiates and directs
translocation of Rols7. (A–J) Full-length Duf, membrane-
anchored Duf EC or IC regions (red) were expressed
alone or together with Rols7 (green) in S2 cells. Dashes
outline cell surface. Hoechst-labeled DNA in blue. (K–Q)
WT (early stage 15) and mutant embryos (stage 16) were
stained with anti-Rols7 (green) and anti-myosin heavy
chain (MHC, red) to determine Rols7 distribution in rela-
tion to myoblast adhesion. Schematics show founders/
myotubes in gray, fcm in red, and Rols7 in green (or yellow
when it overlaps with MHC); arrowheads highlight fcm
that adhere to founders/myotubes. 
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the intact Duf receptor precedes and is necessary to direct
movement of Rols7 puncta to where Duf is located.
If either homo- or heterophilic engagement of the Duf re-
ceptor can induce Rols7 to translocate, why does translocation
during myoblast fusion occur at sites of adhesion between
founders/myotubes and fcm and not at sites of contact between
neighboring founders and/or myotubes (Fig. 3 K)? Analyses of
mutants such as 
 
myoblast city
 
 (
 
mbc
 
; Erickson et al., 1997),
 
blownfuse
 
 (
 
blow
 
; Doberstein et al., 1997), 
 
Drosophila-myocyte
enhancer factor 2
 
 (
 
D-mef2
 
; Bour et al., 1995; Lilly et al.,
1995), and 
 
hbs
 
 show that translocation of Rols7 remains unper-
turbed and Rols7 is present where fcm contact the founders
(Fig. 3, L and M; Menon and Chia, 2001; unpublished data).
In contrast, in 
 
lame duck
 
 (
 
lmd
 
; also known as gleeful or my-
oblasts incompetent) mutants (Duan et al., 2001; Furlong et al.,
2001; Ruiz-Gomez et al., 2002) where fcm are absent and fusion
does not occur, Rols7 translocates to founder–founder contact
sites instead (Fig. 3 N). Similarly, when fcm fail to express both
SNS and Hbs or SNS alone, and are no longer attracted toward the
founders, Rols7 becomes enriched at the adhesion sites between
founders (Fig. 3, O and P). Examination of Duf distribution re-
veals that it parallels that of Rols7 in each of these mutants (see
next section). We conclude that in myoblasts, heterophilic interac-
tion between Duf and SNS is favored over homophilic Duf inter-
action, thus targeting Duf and Rols7 to sites of adhesion between
founder/myotube and fcm. However, in the absence of SNS, Duf
is free to engage itself and, in doing so, directs Rols7 there.
 
Early and later myoblast fusions differ in 
their requirements of the Duf receptor
 
To understand how Duf promotes fusion, we introduced vari-
ous Duf constructs into myoblasts lacking Duf and its para-
Figure 4. Functional analyses of Duf. (A–H)
Full-length and Duf deletions were introduced
into duf, rst mutants using the 24B-gal4 driver.
Embryos were stained with anti-MHC antibod-
ies (A, C, E, and G, showing dorsal muscles)
or double labeled with antibodies against Eve
(green nuclear stain) and either D-Titin (B, red
cytoplasmic stain) or MHC (D, F, and H).
Founders and myotubes outlined with dashes;
arrowheads indicate adherent fcm. (I–K) Res-
toration of myoblast attraction as gauged by
clustering of somatic fcm at epidermal sites
from ectopic expression of constructs using the
wingless (wg)-gal4 driver. Panels show ventral
view of late stage 14 embryos with ventral
midline demarcated by dashes. Anti-MHC
stain (red) marks myoblasts and anti-Wg stain
(green) marks the alternating strips of wg-gal4-
driven expression domains in the epidermis.
Mutant embryos expressing NT(TM)-Flag show
fcm extending filopodia toward and adhering
to the Wg-expressing epidermal regions (J) in
contrast to nonexpressing or NT-Flag–express-
ing mutant embryos where fcm are not seen
(I and K). (L) Extent of fusion in the somatic
muscles was assessed based on the average
number of Eve-positive nuclei within DA1 mus-
cles at stage 15, denoted as “N”   SD, from
three independent experiments where 20–30
abdominal hemisegments from two to three
embryos were analyzed at a time. A WT DA1
contains an average of 10 nuclei (n   9.9  
0.3, whereas those in duf;rst
Df(1)w67k30 mutants
are mono-nucleated (n   1.0   0.0). Embryos
were also stained with an antibody against
Rols7 to ascertain its localization. Results are
summarized in M. Yellow bar, TM region; or-
ange oval, Flag tag; black circles, immuno-
globulin repeats; Y (yes), N (no), Y/N (par-
tial). As expression levels of Duf constructs in
myoblasts was beyond the sensitivity of detec-
tion, its localization in M is as observed when
constructs are ectopically expressed in the
epidermis or salivary gland. 
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logue Rst (henceforth, referred to as 
 
duf, rst
 
 mutants) and as-
sessed the extent to which fusion occurred (see Fig. 4 M for
summary of results). In 
 
duf, rst
 
 double mutant embryos, the
founders fail to attract fcm, Rols7 does not translocate and fu-
sion stalls altogether (Fig. 3 Q). With the reintroduction of ei-
ther untagged or Flag-tagged full-length Duf, the ability of
founders and myotubes to attract fcm is restored, Rols7 trans-
locates to fcm-founder/myotube adhesion sites and fusion oc-
curs to a significant extent. This culminates in a WT muscle
pattern in every segment (Fig. 4, compare A with C). Quantifi-
cation of the Eve-expressing nuclei shows that a WT DA1
myotube contains an average of 9.9 
 
 
 
 0.3 nuclei at stage 15,
whereas its equivalent in mutants expressing full-length Duf
comprises at least 6.6 
 
 
 
 0.8 nuclei (Fig. 4, compare B with D;
Fig. 4 L).
Expression of the membrane-anchored Duf EC region
NT(TM)-Flag restores fcm attraction and adhesion (Fig. 4,
compare I with J) but does not trigger Rols7 translocation (un-
published data). Nevertheless, a small degree of fusion occurs
and most of the DA1 muscles develop into bi-nucleated precur-
sors (
 
n 
 
  
 
1.8 
 
 
 
 0.3), a phenotype analogous to that seen in em-
bryos lacking 
 
rols
 
 (Fig. 4, E, F, and L). On the other hand, em-
bryos expressing the soluble Duf EC region NT-Flag fail to
exhibit any myoblast attraction and there is neither transloca-
tion nor rescue of the aberration (Fig. 4, compare K with I–J
and L). Expression of the Duf IC region either as the mem-
Figure 5. Distinct regions of Rols7 perform
different functions. (A–F) HA-tagged full-length
Rols7, deletions, and point mutations of cata-
lytic residues in the putative lipolytic enzyme
signature sequence were expressed alone or
with Duf in the salivary gland. Glands were
stained with an antibody against HA to as-
certain Rols7 localization (green, constructs
shown schematically in H). (G) Constructs
were introduced into rols
P1729ex18/Df(3L)BK9
mutant myoblasts using the 24B-gal4 driver
and extent of fusion assessed by the average
number of Eve-positive nuclei, “N”   SD,
within a DA1 muscle at stage 15 in compari-
son to 9.9   0.3 in WT and 3.3   0.2 in rols
mutants. Data represent results from three inde-
pendent experiments in which 20–30 abdomi-
nal hemisegments from two to three embryos
were analyzed each time. (H) Summary of
data obtained in G. Rols7 subcellular distri-
bution was ascertained as described before.
L (red), putative lipolytic enzyme sequence; R
(orange), RING finger; U (white box), a re-
gion in Rols7 that is absent in Rols6; A (blue),
ankyrin repeats; T (green), TPR repeats; black
dash, coled-coil region; yellow oval, HA tag;
Y (yes), N (no), Y/N (partial); nd, not de-
tected. Position of tag in construct indicated
by where “HA” is placed in nomenclature. 
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brane-anchored or soluble form also fails to confer attraction or
induce Rols7 translocation, and fusion remains completely dis-
rupted (Fig. 4 L). Concurrent expression of the membrane-
anchored Duf EC and IC regions does not reconstitute func-
tions of the intact receptor and fusion stalls after precursors
form (unpublished data). Collectively, these data show that the
attractant properties of Duf reside wholly in a membrane-
anchored EC region and that this region is sufficient to initiate
the first round of fusion leading to the development of the pre-
cursor. However, fusion beyond this stage requires both the
membrane-anchored EC and IC regions to be present as a single
entity. The inability of precursors to fuse, despite conditions that
sustain expression of the attractant NT(TM)-Flag and maintain
adhesion between fcm and precursors (Fig. 4 F, arrowheads), un-
derscores the need for IC events such as the translocation of
Rols7 to take place before fusion can proceed. None of the ex-
pressed mutants showed dominant negative effects.
 
Distinct regions of Rols7 perform 
different functions: ankyrin repeats 
confer Duf responsiveness, whereas the 
TPR/coiled-coil region confers myoblast 
fusion competence
 
To delineate the functional region(s) of Rols7, we introduced
HA-tagged Rols7 constructs deleted progressively from the
NH
 
2 
 
or COOH terminus into the salivary gland epithelium and
tested if these translocated in the presence of Duf (Fig. 5, A–F;
Fig. 5 H shows schematic structure of constructs. All con-
structs were sequenced in their entirety. Transcripts were de-
tectable by RNA in situ hybridization and, with the exception
of HA-Rols7 (
 
 
 
1-863) and (
 
 
 
1-1150), proteins were produced
at comparable levels, as seen on Western blots; Fig. S1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200501126/
DC1). We also introduced the constructs into 
 
rols
 
 mutant myo-
blasts to ascertain the effect on fusion (Fig. 5 G and Fig. 5 H,
summary of results). Full-length Rols7 tagged at either its NH
 
2
 
or COOH terminus associates with distinct puncta, just like the
untagged protein, translocates to the apical surface in polarized
cells or the fcm-founder/myotube adhesion site and restores fu-
sion (Fig. 5, A, B, and G). Analyses of DA1 muscles reveal an
average of at least 9.3 
 
 
 
 1.3 Eve-expressing nuclei per muscle
in embryos rescued using full-length Rols7, within the limits of
the “N” value for WT muscles, and a marked increase from 3.3 
 
 
 
0.2 in 
 
rols
 
 mutants. Surprisingly, removal of the first 309 aa
unique to Rols7 and absent in the alternatively spliced Rols6
(Menon and Chia, 2001) or point mutations of the catalytic
residues of a putative lipolytic enzyme signature sequence en-
compassed within this region, does not lead to any deleterious
effects. Similarly, construct HA-Rols7 (
 
 
 
1-439), where the de-
letion extends to remove the RING finger, is functionally
equivalent to full-length Rols7. On the other hand, constructs
HA-Rols7 (
 
 
 
1-863) and (
 
 
 
1-1150) that lack the other unique
region encoded by exon 6 in 
 
rols7
 
 cannot be detected, suggest-
ing that this region is likely to confer protein stability. Consis-
tently, Rols6 is not detected when ectopically expressed in the
salivary gland or 
 
rols
 
 mutant myoblasts and fusion is also not
restored (Fig. 5 G).
A COOH-terminal deletion construct lacking the tetratri-
copeptide repeats (TPRs) and coiled-coil region, Rols7-HA
( 1739-1900), no longer associates with discrete puncta and
instead appears diffused in the cytoplasm (Fig. 5, compare C
with A). However, this truncation remains fully Duf responsive
and translocates efficiently (Fig. 5, compare C with D). When
introduced into rols mutant myoblasts, fusion occurs to a
greater extent (n   5.7   1.3) but not to a degree that produces
a functional musculature—most of these embryos are unable to
hatch and eventually die, like rols mutant embryos (Fig. 5 G).
A deletion that also removes the ankyrin repeats, Rols7-HA
( 1401-1900), results in a truncated protein that fails to trans-
locate in the presence of Duf and is unable to rescue the fusion
defect (Fig. 5, compare E with F and G). Hence, Rols7 com-
prises regions that perform distinct functions—the ankyrin re-
peats are essential for Duf-dependent translocation, whereas
the TPR/coiled-coil region functions after translocation. Al-
though both these regions are present in Rols6, Rols6 is not stable
when ectopically expressed and cannot substitute for Rols7.
None of the constructs showed dominant negative effects.
Rols7 sustains myoblast fusion by 
maintaining Duf expression at the 
precursor surface
How does Rols7 sustain fusion? Our observation that fusion
beyond the precursor stage requires intact Duf (and Rols7)
prompted us to analyze Duf expression during fusion. In situ
indirect immunofluorescent stains using antibodies raised
against the bulk of the EC region of Duf (Galletta et al., 2004)
as well as an antibody raised against an IC region that is unique
to Duf detect ectopically expressed Duf at the surface in a vari-
ety of tissues such as the salivary glands, epidermis, central and
peripheral nervous systems, amnioscerosa, and developed mus-
cles (Fig. 2; Fig. 6, O–Q; Fig. S2, F–H, available at http://
www.jcb.org/cgi/content/full/jcb.200501126/DC1). In con-
trast, endogenous Duf or that which is driven with gal4 drivers
is largely seen as puncta within the cytoplasm of actively fus-
ing myotubes at stage 13/14 and is rarely detected at the myo-
tube surface using either of the two anti-Duf antibodies or anti-
Flag antibodies, despite an abundance in duf mRNA (Fig. 6, A,
I–N; Fig. S2, A and F–H). Nevertheless, in fusion mutants such
as blow, lmd, D-mef2, mbc, sns, and hbs;sns, endogenous Duf
or ectopically expressed Duf-Flag becomes clearly visible at
the founder/myotube surface (Fig. 6, B–D, and G; Fig. S2,
B–D; unpublished data). Where fcm differentiate and express
SNS, Duf is seen enriched at adhesion sites between fcm and
founders (Fig. 6 B). On the other hand, absence of the entire
fcm population or just the lack of SNS on fcm changes this dis-
tribution pattern; Duf now localizes at adhesion sites between
neighboring founders in lmd and sns single mutants and hbs;
sns double mutants (Fig. 6, C and D; unpublished data). It thus
appears that the level of Duf at the surface of WT myoblasts
and enlarging myotubes is tightly controlled posttranscription-
ally. In mutants where fusion is disrupted or in WT embryos
where fusion is over, this control is overcome thereby elevating
the level of Duf to a point that allows its detection at the
myoblast/myotube/muscle surface.JCB • VOLUME 169 • NUMBER 6 • 2005 916
Of the mutants tested, rols is an exception in that Duf
could not be detected at fcm-precursor adhesion sites and was
also seen at relatively lower levels within the precursor cyto-
plasm (Fig. 6, E and F; Fig. S2 E). The inability to detect Duf at
the surface here cannot be accounted for on the basis of myo-
tube size because Duf is clearly seen in the equally small tri-
nucleated precursors that sometimes develop in blow and sns
mutants (Fig. 6, compare E with B and D; Fig. 6 R, “N” value
of fusion mutants). Strikingly, D-mef2;rols double mutant em-
bryos no longer exhibit the elevated levels of Duf seen in D-mef2
single mutants (Fig. 6, compare G with H). This and the failure
to sustain myoblast attraction and adhesion in the absence of
Rols7 show that Rols7 plays a role in maintaining Duf at the
surface of precursors through directional transport (Fig. 6,
compare E with F, fcm initially cluster and adhere to rols mu-
tant precursors but this process is not sustained). The manifes-
tation of a similar phenotype in rols mutant embryos express-
ing Rols7-HA ( 1739-1900), a truncation that lacks the TPR/
coiled-coiled region but nevertheless translocates efficiently,
suggests that precursors do not maintain expression of surface-
localized Duf here as well.
Attempts to bypass the need for Rols7 through gal4-
UAS–driven Duf expression in the rols null background neither
enables detection of Duf at the precursor surface nor restores
the attraction and adhesion between fcm and precursors (un-
published data). Similarly, overexpression of Rols7 alone or
Rols7 and Duf in WT myoblasts and actively fusing myotubes
does not lead to elevated Duf expression at the surface (Fig. 6,
I–N). Hence, Rols7 is essential but not sufficient for the main-
tenance of surface levels of Duf in precursors.
Discussion
The formation of the myotube is a fundamental part of myo-
genesis in many organisms. In Drosophila, the advent of a bi-
or tri-nucleated syncytial precursor marks the earliest stage in
the formation of a myotube and subsequent fusions lead to a
gradual increase in myotube size (Bate, 1990). Our results in-
dicate that Duf is a key component in both the initial and sub-
sequent fusions and its expression at the founder/enlarging
myotube cell surface is under tight regulation. Functionally
active Duf requires molecular integrity because its IC region-
Figure 6. Rols7 sustains Duf expression and allows fusion to progress. (A–F) WT and mutant embryos were double labeled with an antibody raised
against the Duf EC region (green) and another against MHC (red). Schematics depict founders/myotubes in gray, fcm in red and Duf in green (or yellow
where it overlaps with MHC); arrowheads show adherent fcm. (G and H) Embryos carrying the D-mef2 mutation alone (G) or in combination with the rols
mutation (H) were stained with antibodies raised against Eve (red nuclear stain), Rols7 (red cytoplasmic stain), and the Duf IC region (green cytoplasmic
stain). Dashes outline founders. (I–Q) Indirect immunofluorescent analyses of ectopically expressed epitope-tagged Duf and Rols7. (I–K) Actively fusing dor-
sal myotubes at stage 13/14 with DA1 labeled with anti-Eve (blue nuclei). (L–N) Ventral myotubes at stage 13/14. (O–Q) After fusion ventral muscles at
stage 16. Schematics show myotubes/muscles in gray and overlapping Duf and Rols7 expression in yellow. When ectopically expressed in actively fusing
myotubes, both Duf and Rols7 are visible as cytoplasmic puncta and rarely seen as “dashes” or “lines” at the myotube surface (L and N, arrowheads).
At stage 16, both proteins clearly localize at the surface of the ventral muscles, particularly at muscle-muscle adhesion sites. (R) The extent of fusion in
various mutants gauged by the average number of Eve-positive nuclei “N”   SD within a DA1 muscle at stage 15. Data represent results from three
independent experiments in which 20–30 abdominal hemisegments from two to three embryos were analyzed at a time.POSITIVE FEEDBACK LOOP DURING MYOTUBE GROWTH • MENON ET AL. 917
dependent Rols7 translocation is regulated in cis by the homo/
heterophilic interactions of its chemoattractive EC region.
Adhesion between Duf and fcm-expressed SNS (and Hbs to a
lesser extent) triggers and directs movement of Rols7-vesicles
to the fusion site, replenishing Duf at the cell/myotube surface.
This Duf–Rols7 positive feedback loop enables the progression
of fusion at specific sites and highlights a means of gating the
growth of the myotube.
From myoblast adhesion to Rols7 
translocation: the intact Duf receptor 
as a transducer of an EC event into an 
IC response
A salient feature of the Duf-dependent Rols7 translocation is
most evident in S2 cells. In these cells, sites where Rols7
translocates to clearly coincide with regions along the cell
membrane where Duf mediates homo- or heterophilic adhe-
sion between cells, where Duf itself is seen to be enriched, and
not elsewhere along the cell membrane where Duf may also be
present (Fig. 3, E and F). Hence, association with itself or SNS
in trans confers upon Duf the ability to trigger the relocation of
Rols7 puncta. In epithelial cells where Duf is targeted to the
apical cell surface, Rols7 translocates only to the adherence
junctions suggesting that Duf–Duf interaction at contact points
between neighboring cells is required for translocation here as
well (Fig. 1, B and D). Consistently, a membrane-anchored
Duf truncation lacking the EC region no longer accumulates at
epithelial adherence junctions and fails to bring about Rols7
translocation (Fig. 2 L). In view of this requirement for Rols7
translocation, it is plausible that the inability to detect Duf with
an NH2-terminal Flag tag at adherence junctions (although this
construct can be seen elsewhere along the apical surface using
anti-Flag antibodies and is detected at adherence junctions us-
ing antibodies against its IC region) is due to masking of the
Flag epitope by homophilic engagement, rather than cleavage
and shedding of the Duf EC region (Fig. 2 H). In myoblasts,
sites of Rols7 translocation also overlap with points of adhe-
sion, where Duf itself is seen to localize (Fig. 3, K–P; Fig. 6,
B–D). However in the presence of SNS-expressing fcm, there
appears to be a preference for Duf–SNS interaction over Duf–
Duf interaction and Rols7 translocates specifically to sites of
heterophilic adhesion. The observation that Duf–SNS-induced
S2 cell adhesions form more rapidly and to a greater extent
than Duf–Duf adhesions supports our findings (Galletta et al.,
2004). Although fusion is not perturbed to any significant ex-
tent in hbs mutants, Duf-Hbs heterophilic adhesion could play
a minor role in mediating the initial fusion as suggested by the
presence of largely bi-nucleated precursors in sns mutants in
contrast to hbs;sns double mutants where founders are mostly
mono-nucleated (Fig. 6 R). Hence, Rols7 translocation does
not arise as a result of constitutive Duf-dependent targeting of
preformed Duf–Rols7 complex to the cell surface or movement
of newly synthesized Rols7 to where Duf is surface localized
and unengaged. As the TM and/or cytoplasmic tail of SNS is
also crucial for membrane fusion, it is possible that analogous
adhesion-induced IC events occur in the fcm in parallel (Gal-
letta et al., 2004).
Perpetuating the cycle of myoblast 
adhesion and fusion through Rols7 
translocation during enlargement of 
the precursor
The duf mRNA is detectable in myotubes so long as they are in-
creasing in size through fusion with fcm, after which expression
declines and is eventually lost altogether (Ruiz-Gomez et al.,
2000). Although the duf protein can be detected within cytoplas-
mic puncta, its level at the founder/fusing myotube surface is not
commensurate with its transcript level and we are rarely able to
detect Duf here, even at a time when fusion with fcm is at its
peak. Importantly, attempts to boost its levels at the surface of
myoblasts/fusing myotubes using various gal4-UAS combina-
tions were unsuccessful, despite enhancement of its transcript
level over that in WT embryos (Fig. 6, I–N; Fig. S2, F–H). As
translocation of Rols7 to the cell surface is dependent on sur-
face-localized Duf, we also analyzed surface levels of Rols7 in
embryos overexpressing both Rols7 and Duf as an indirect mea-
sure of Duf localization. Although cytoplasmic levels of Rols7
were markedly elevated over that in WT stage 13/14 embryos,
there was no significant increase in surface-localized Rols7, thus
reflecting a lack of enrichment of Duf at the myoblast/enlarging
myotube surface. This pattern changes at stage 16, when sur-
face-localized Rols7 (and Duf) clearly outline the muscle sur-
face, particularly at muscle-muscle adhesion sites (Fig. 6, O–Q).
Duf also becomes detectable when myoblast fusion is dis-
rupted (Fig. 6, B–D). In most fusion mutants, its expression is
up-regulated to a point where it is clearly seen at sites of myo-
blast adhesion. At the same time, these mutants display en-
hanced levels of Rols7 expression and Rols7 is also seen at
myoblast adhesion sites. This, the loss of attraction between
fcm and rols
- precursors, and failure to detect Duf specifically
in rols
- embryos show that Rols7 is required for accumulation
of Duf at the founder/precursor surface. The observation that
D-mef2 mutants no longer exhibit increased Duf levels when
Rols7 is absent further supports this conclusion (Fig. 6, G and
H). Of note, surface levels of the paralogue Rst may also be
tightly regulated as analyses using antibodies raised against the
EC region of Duf, a region that is highly conserved in Rst,
yielded data similar to that using antibodies against an IC region
unique to Duf (Strunkelnberg et al., 2001; Galletta et al., 2004).
How might Rols7 affect Duf/Rst expression level? The
concurrent loss of Duf and its paralogue Rst leads to a com-
plete block in myoblast fusion, demonstrating that these mole-
cules must be present for the fusion process to start (Fig. 6 R).
In contrast in the rols null allele, fusion is not abrogated alto-
gether. Here, an initial round of fusion occurs and generates bi-
and tri-nucleated syncytial precursors (Fig. 6 R; Menon and
Chia, 2001; Rau et al., 2001). Thereafter, fcm attraction and ad-
hesion to precursors sharply declines and myotube enlargement
stalls (Fig. 6, E and F). Hence, the first round of fusion is
clearly Duf/Rst dependent but Rols7 independent, whereas sus-
tenance of the fusion cycle needs Rols7. Given that the punc-
tate staining of Rols7 in all cell types tested is indicative of its
association with an endosomal compartment, and that Duf can
colocalize with these Rols7-positive vesicles, it is plausible that
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lowed by its fusion with the cell membrane replenishes Duf/Rst
at the cell surface (colocalization of Duf and Rols7 within vesi-
cles most apparent in S2 cells; Fig. 3, G and J). It is likely that
other components of the fusion machinery are replenished at
the same time through translocation of Rols7- and/or Loner-
associated vesicles because duf, rst double mutant founders ex-
pressing NT(TM)-Flag, a membrane-anchored Duf truncation
lacking the IC region, undergo one cycle of fusion but fail to
enlarge any further (Fig. 4, E, F, and L). For Rols7 to respond
to the Duf/Rst-induced changes within the cell through translo-
cation, its ankyrin repeat region must be intact (Fig. 5, E–G).
However, translocation per se is insufficient for the sustenance
of surface-localized Duf/Rst and progression of fusion because
only partially formed myotubes are generated when rols mu-
tant founders express the translocation-effective Rols7-HA
( 1739-1900), a construct lacking the TPR/coiled-coiled mo-
tifs (Fig. 5, C, D, and G). Based on the precedence of the
coiled-coiled motif in promoting IC membrane fusion, we de-
duce that the Rols7 COOH-terminal region mediates fusion
between the membranes of its host vesicle and the founder/
precursor surface (Skehel and Wiley, 1998).
These data emphasize the complex nature of myoblast fu-
sion. Although components of the fusion machinery, such as
Duf and Rols7, are both expressed in founder myoblasts at the
onset of fusion, the dynamics of their subcellular distribution
differs. In our model (Fig. 7), Duf is first targeted to the
founder cell surface. Its localization at this time is independent
of Rols7. Contact between fcm and founders lead to the rela-
tively stable Duf–SNS interaction, culminating in fcm-founder
adhesion and fusion between these closely juxtaposed cell
membranes. At the same time, Duf-mediated cell adhesion ini-
tiates changes within the cell that lead to cell polarization, such
that translocation of Rols7-vesicles is targeted only to sites
along the membrane where the first lot of Duf engages in adhe-
sion. With the fusion of these vesicles to the precursor mem-
brane, another batch of Duf (and other fusion machinery) be-
comes deposited at the cell/precursor surface, this time in a
Rols7-dependent manner, and fuels the next round of myoblast
fusion. On the surface of the vesicle, Rols7 may interact with
the IC region of Duf because significant colocalization is ob-
served in puncta between Rols7 and full-length Duf-Flag or
Flag-(TM)CT but not with NT(TM)-Flag (Fig. 3, compare G
and J with H and I). This point is exemplified by coimmuno-
precipitation of Rols7 with either full-length Duf or a fragment
encompassing the IC region (Chen and Olson, 2001).
By maintaining low levels of key components of the fu-
sion machinery such as Duf and regulating its localization at
fusion sites through Rols7, the enlargement of the myotube is
made to occur in stages, irregardless of the final size of the
muscle. Restriction of myoblast fusion to specific sites along
the membrane and the stepwise size increase may be critical for
proper coordination between the multiple events occurring at
this time and prevent loss of myotube structural integrity, as
seen when its enlargement is artificially accelerated in cultured
myoblasts (Yagami-Hiromasa et al., 1995).
Materials and methods
Drosophila strains
The following strains were used: Canton-S, rols
Df(3L)BK9, da-gal4, and elav-
gal4 (from the Flybase consortium); D-mef2
22-21 (Bour et al., 1995), duf;
rst
Df(1)w67k30, and UAS-duf transgenic flies (Ruiz-Gomez et al., 2000);
sns
ZF1.4, sns
XH2, sns
XB3 (Bour et al., 2000); mbc
D11.2 (Erickson et al., 1997);
lmd
1 (Duan et al., 2001); hbs
459 and hbs
2593;sns
XB3 (Artero et al., 2001);
blow
2 (Doberstein et al., 1997); the rols allele P1729ex18, rP298-gal4,
UAS-rols6, and UAS-rols7 transgenic flies (Menon and Chia, 2001); 24B-
gal4 (Zaffran et al., 1997); and wg-gal4 (Glise and Noselli, 1997).
Epitope-tagged duf and rols7 constructs
Full-length Duf with a Flag tag at its NH2-terminal (Flag-Duf) was made by
inserting the epitope tag downstream of the signal sequence after amino
acid 75. Flag-(TM)CT contains Flag in a similar position but lacks the seg-
ment encoding amino acids 103–553. Flag-CT carries the epitope tag just
after the translation start site but lacks amino acids 2–611. To create full-
length Duf with Flag at its COOH-terminal (Duf-Flag), we inserted the
epitope tag just before the translation stop site. NT(TM)-Flag and NT-Flag
carry the epitope tag at the end of the COOH-terminal as well but lack
amino acids 610–959 and 586–959, respectively.
Figure 7. Schematic of events envisaged to occur in WT and mutant
myoblasts. (Top) Duf localizes at the WT founder cell surface. Its EC region
serves as an attractant, binds Hbs and SNS and, in doing so, brings about
adhesion between founder and fcm. The first round of intercellular fusion
ensues, culminating in the formation of a precursor, and this may result in
the cleavage/removal of the Duf receptor from the cell surface. At the same
time, adhesion between the founder and fcm initiates IC events in the
founder that lead to translocation (and possibly fusion) of Duf-loaded Rols7
vesicles to the adhesion site. The new batch of Duf at the surface initiates
another round of myoblast fusion. (Middle) In mbc or D-mef2 mutants, en-
gagement of Duf induces Rols7 vesicles to translocate and deposit the next
batch of Duf at the founder cell surface. However, in these mutants, fusion
does not occur and the persistent adhesion between fcm and the founder
leads to additional Rols7 and Duf being deposited at the founder surface.
In lmd and sns mutants, similar events triggered by homophilic Duf adhe-
sion causes Rols7 and Duf to be targeted to sites of contact between
founders. (Bottom) In the rols mutant, the first round of fusion occurs undis-
rupted. However, without Rols7, Duf levels at the precursor surface is not
replenished and fusion stalls. Surface levels of Rst may be similar regulated.POSITIVE FEEDBACK LOOP DURING MYOTUBE GROWTH • MENON ET AL. 919
HA-tagged full-length Rols7 constructs were created by placing the
epitope tag just after amino acid 130 (HA-Rols7) or before the translation
stop site (Rols7-HA). HA-Rols7 ( 1-137) was made by deleting the Rols7
NH2-terminal up to amino acid 137 and replacing it with a PCR product
carrying the HA epitope immediately after the translational start site. This
construct was used to produce the NH2-terminal truncations HA-Rols7 ( 1-
264), ( 1-439), ( 1-863), and ( 1-1150) by deleting the regions de-
picted in the nomenclature for each construct. The Rols7 COOH-terminal
deletion constructs Rols7-HA ( 1739-1900) and ( 1401-1900) carry the
HA epitope at the end of the COOH-terminal and lack the regions shown
in the construct nomenclature. Point mutations of the putative lipolytic se-
quence were made by converting serine residues 241 and 243 to alanine.
Expression of constructs in Cos and S2 cells
Cos cells were grown at 37 C in Dulbecco’s minimum essential medium
(GIBCO BRL); S2 cells were cultured at 25 C in M3 insect media (Sigma-
Aldrich). Both media were supplemented with 10% heat-inactivated FBS
(Hyclone). For immunostaining, S2 cells were made to adhere by culturing on
poly-L-lysine–coated coverslips (Iwaki). Constructs were subcloned into pCIneo
(Promega) or pAc5.1 vectors (Invitrogen) and then transfected into Cos or S2
cells, respectively, using Effectene (QIAGEN). Cells were processed for stain-
ing 24 h (Cos) or 48 h (S2) after transfection (Singh et al., 1993).
Germline transformation and gal4-UAS–driven expression studies
Transgenic flies were generated as described previously (Spradling,
1986). Constructs were cloned into the pUAST vector and expressed using
gal4-UAS (Brand and Perrimon, 1993). Results are representative of data
obtained using at least two independent insertions for each transgene. Ec-
topic expression studies were done using a copy each of the elav-gal4 or
wg-gal4 drivers and the UAS-controlled construct(s) of interest. Expression
in embryonic myoblasts was performed using single copies of 24B-gal4
and UAS-controlled gene(s) of interest in either the duf, rst double mutant
Df(1)w
67k30, the rols mutant 1729ex18/Df(3L)BK9, or WT embryos.
Immunostaining
Polyclonal rat antiserum was prepared against a COOH-terminal histidine-
tagged fusion peptide encompassing the amino acid residues 942–955 of
Duf, which are absent from the structurally related Rst protein.
Immunostains were performed as described previously (Menon and
Chia, 2001). The following primary antibodies were used: mouse anti-
MHC (Kiehart and Feghali, 1986), anti-Wg, and anti-Crumbs (Develop-
mental Studies Hybridoma Bank) and anti-tubulin (Sigma-Aldrich); rabbit
anti-MHC (a gift from D. Kiehart, Duke University, Durham, NC), anti–
 -galactosidase (Cappel), anti-Eve (Frasch et al., 1987), anti-FLAG (Affin-
ity BioReagents, Inc.), and anti-Rols (ANTS antibody; Chen and Olson,
2001); rat anti-Crumbs (Tepass et al., 1990), anti-HA (Roche), rat or
mouse anti-Rols7 (this work; Menon and Chia, 2001); and guinea pig
anti-Duf/Rst antibody (Galletta et al., 2004). Secondary antibodies were
conjugated to Cy3 or FITC (Jackson ImmunoResearch Laboratories). DNA
was labeled using Hoechst (Sigma-Aldrich). Samples were mounted in
Vectashield. Images were acquired using a LSM 510 Meta confocal mi-
croscope (40  Plan Neofluar lens, NA   1.3; Carl Zeiss MicroImaging,
Inc.) or a digital camera (model DXM 1200F; Nikon) mounted onto a
Axioplan 2 microscope (10  Plan Neofluar lens, NA   0.3, 40  Plan
Neofluar lens, NA   1.3 [Carl Zeiss MicroImaging, Inc.], acquisition soft-
ware [Nikon ACT-1]) at  22 C.
Online supplemental material
Fig. S1 shows RNA in situ and Western blot analyses of HA-tagged Rols7
constructs. Fig. S2 shows indirect immunofluorescent analyses of embryos
using anti-Duf specific antibodies. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200501126/DC1.
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